Verrica, Torii Amend Deal to Launch Global Phase 3 Trial for YCANTH
July 1, 2025
Verrica to receive a $8 million milestone payment for initiation of the global study in July 2025, ahead of previous schedule Verrica Pharmaceuticals, a dermatology
